Concepedia

Publication | Open Access

A Phase III Randomized, Double-Blind, Trial Comparing Sorafenib Plus Capecitabine Versus Placebo Plus Capecitabine in the Treatment of Locally Advanced or Metastatic Her2-Negative Breast Cancer (Resilience)

DOIFull Paper Access

18

Citations

0

References

2014

Year

José Baselga, Claudio Zamagni, P. Gómez, Begoña Bermejo, Shigenori E. Nagai, Bohuslav Melichar, Arlene Chan, L. Mangel, Jonas Bergh, Frederico Costa,
Annals of Oncology

No additional data available for this publication yet. Check back later!